DUBLIN--(BUSINESS WIRE)--The "Data Integrity by Design and Pharma 4.0: Next-Gen Techniques to Approach GxP Systems, and FDA Compliance" training has been added to ResearchAndMarkets.com's offering.
AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...
ACD/Labs updates Katalyst D2D with new automation, data integration and workflow tools to speed drug development.
Eva-Maria Hempe, NVIDIA, says bio/pharma must centralize AI strategy, tackle silos, prioritize process integrity, and balance quick wins with long-term drug design goals.
In an industry where speed and precision can directly affect patient outcomes, pharma companies are under pressure to ...
Modern laboratories in quality control need solutions that ensure precise analysis, lasting reliability, and secure digital ...
As direct-to-patient deliveries of temperature-sensitive medications rise, the pharmaceutical industry is racing to protect ...
Data integrity is an ongoing concern across all R&D organizations, no matter what part of the research lifecycle they’re navigating. These concerns extend beyond the potential for delayed timelines or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback